Methasterone
Methasterone (Superdrol): the designer steroid once sold as a supplement, its Schedule III status, the liver injury reports and other risks.
Not approved, Schedule III · Evidence grade C · Reviewed
Not approved by the FDA for human use. Not for human consumption. This page describes Methasterone only to explain its regulatory status, what has been studied and its known risks. Drawline does not recommend obtaining or using it. Disclaimer
- No current approved medical use in the US.
Methasterone (Superdrol, methyldrostanolone). Oral anabolic steroid.
CNot approved, Schedule III. Evidence grade C: limited, early or dated human data.
What is Methasterone?
Methasterone is an oral anabolic steroid. It was sold in the mid-2000s as Superdrol, a so-called supplement for bodybuilding.
Is Methasterone legal and FDA-approved?
Methasterone has no approved medical use in the United States. FDA sent a warning letter over Superdrol in March 2006. DEA classified it as a Schedule III anabolic steroid in a final rule published July 30, 2012, effective August 29, 2012, and Congress later named it in the federal definition in 2014.
What does the evidence show for Methasterone?
No clinical trials. Human data come from case reports and case series of liver injury in people who took it.
What are the known risks of Methasterone?
It is a 17α-alkylated oral steroid, the type most linked to liver injury. Doctors have reported severe cholestatic liver injury (bile backing up, with jaundice) in previously healthy users, sometimes with kidney failure, and in some cases it got worse after they stopped. Anabolic steroids can cause mood and behavior changes and psychological dependence. They suppress natural testosterone and fertility, and are linked to heart, liver and hormonal harm. Non-medical users often take 10 to 100 times the medical dose, which raises every risk. WADA bans it at all times as an anabolic androgenic steroid (class S1.1).
How is Methasterone measured?
A tablet, so there is nothing to draw or calculate.
Sources: Federal Register: methasterone and prostanozol classified as Schedule III (2012); PubMed: methasterone-associated cholestatic liver injury in 5 cases; FDA: body-building products labeled to contain steroids continue to cause serious liver injury; NIH LiverTox: androgenic steroids; DEA: controlled substances by drug code number. This profile does not recommend any dose or use.
For research and educational use. Not medical advice. Regulatory status changes, so confirm the current position with FDA or a licensed professional.
Keep reading
Spot a mistake or an out-of-date fact? Report an error. We check every report against the sources.